6
Oct
2026
Devintec Sagl
Exhibitor at CPHI Milan 2026 stand 18J57, Finished Dosage & Formulation
About Us
Categories
-
Country/Region:Switzerland
-
On CPHI since:2023
-
Employees:1 - 24
Company types
Primary activities
Event information
CPHI Milan 2026
-
6 Oct 2026 - 8 Oct 2026
-
Fiera Milano, Italy
-
Visit us at stand 18J57, Finished Dosage & Formulation
Products Featured at CPHI Milan 2026
-
Product Dermasectan
Dermasectan® is a patented medical device designed to manage and alleviate symptoms of Atopic Dermatitis. Clinically proven to offer similar efficacy to Hydrocortisone, it helps relieve dry, eczematous skin by maintaining a moist environment that supports the natural healing process. Its effectiveness is b... -
Product Gelsectan
Gelsectan® is a patented medical device that restores intestinal function in patients experiencing irregular bowel movements due to Irritable Bowel Syndrome (IBS) related to intestinal hypersensitivity or medication use. It helps relieve and prevent symptoms like chronic or recurring diarrhea, abdominal di... -
Product Gelselax
Gelselax® is a patented medical device specifically designed for patients with IBS-C or functional constipation. Clinical trials have shown that it delivers significant improvement in common symptoms such as constipation, abdominal pain, bloating, and flatulence, with noticeable results within just one wee... -
Product Sectacol
Sectacol® is a patented medical device specifically designed to provide rapid and effective relief from functional bloating and abdominal distention within just 60 minutes. It works by forming a barrier that prevents gas-producing coliforms from adhering to the intestinal wall, reducing their proliferation... -
Product Sorisen
Sorisen® is a patented medical device for patients with hyperkeratosis and skin plaques caused by mild to moderate Psoriasis (psoriasis vulgaris). It has been clinically proven to offer similar efficacy to Calcipotriol/Betamethasone in improving psoriasis symptoms.




